Summary & Overview
CPT 52649: Holmium Laser Enucleation of Prostate with Morcellation
CPT code 52649 represents holmium laser enucleation of the prostate (HoLEP) with mechanical morcellation, a minimally invasive surgical treatment for symptomatic benign prostatic hyperplasia (BPH). Nationwide, this code captures a procedure increasingly used for moderate to large prostate volumes because enucleation plus morcellation allows complete adenoma removal with durable symptom relief and reduced long‑term reintervention. The code matters for hospitals, ambulatory surgery centers, urology practices, and payers because it denotes a definitive surgical approach distinct from transurethral resection or ablative therapies.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find clinical context for when CPT code 52649 is reported, typical sites of service, and operational considerations tied to procedural complexity and equipment (holmium:YAG laser and morcellator). The publication provides benchmarks for utilization and payment where available, summarizes relevant policy themes affecting coverage and site‑of‑service decisions, and highlights coding considerations specific to enucleation with morcellation versus other prostate procedures. Data not available in the input will be identified as such.
Billing Code Overview
CPT code 52649 describes holmium laser enucleation of the prostate (HoLEP) with morcellation performed for benign prostatic hyperplasia (BPH). The procedure involves enucleation of obstructive prostatic tissue using a holmium:YAG laser followed by mechanical morcellation to fragment and remove larger tissue pieces.
Service Type: Surgical procedure — endoscopic prostate enucleation with morcellation
Typical Site of Service: Hospital operating room or ambulatory surgery center (endoscopic surgical setting)
Clinical & Coding Specifications
Clinical Context
A 72-year-old man with progressive lower urinary tract symptoms (urinary frequency, nocturia, weak stream, and sensation of incomplete emptying) refractory to medical therapy presents for surgical management of benign prostatic hyperplasia (BPH). Preoperative evaluation includes history and physical, urinalysis to exclude infection, PSA and prostate imaging or transrectal ultrasound to estimate prostate volume. The patient is scheduled for holmium laser enucleation of the prostate (HoLEP) with mechanical morcellation under general or spinal anesthesia in an ambulatory surgery center or hospital operating room. Intraoperative steps include cystoscopic assessment, holmium:YAG laser enucleation of prostatic adenoma into the bladder, followed by mechanical morcellation and retrieval of enucleated tissue fragments. Postoperative care includes short-term catheterization, monitoring for hematuria and urinary retention, pain control, and discharge instructions with expected improvement in urinary flow and follow-up for pathology results and uroflow/ post-void residual assessment.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when reporting only the physician's professional portion of a service if split billing applies. |
| 50 | Bilateral procedure | Use if bilateral procedure rules apply (procedure performed on both sides when clinically relevant). |